Embecta Corp. distributes regular quarterly cash dividends to its public shareholders, maintaining an active capital return program aligned with its financial cash flows. The company's board of directors routinely declares scheduled dividend payouts, providing a modest dividend yield that is supported by stable earnings from its core global diabetes management supplies and insulin delivery device portfolio.